• Two patients had phenylbutazone-induced systemic vasculitis syndrome. Both presented with acute oliguric renal failure, and renal biopsies showed severe crescentic glomerulonephritis with marked interstitial inflammatory cell infiltration. Withdrawal of phenylbutazone and treatment with immunosuppressives and plasma exchange led to recovery of renal function in one case.
(Arch Intern Med 1985;145:685-687)
Leung ACT, McLay A, Dobbie JW, Jones JMB. Phenylbutazone-Induced Systemic Vasculitis With Crescentic Glomerulonephritis. Arch Intern Med. 1985;145(4):685–687. doi:https://doi.org/10.1001/archinte.1985.00360040109024
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: